| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/283664A0 |
| P698 | PubMed publication ID | 6965520 |
| P2093 | author name string | A Coutinho | |
| N N Iscove | |||
| E L Larsson | |||
| P2860 | cites work | Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s) | Q24679256 |
| Fine specificity of a continuously growing killer cell clone specific for H-Y antigen | Q39572567 | ||
| The Participation of Macrophages and Macrophage Cell Lines in the Activation of T Lymphocytes by Mitogens | Q39802463 | ||
| Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors | Q39899259 | ||
| Accessory cell dependence of lectin-induced proliferation of mouse T lymphocytes | Q40653809 | ||
| Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes | Q40671695 | ||
| T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity | Q40695893 | ||
| Studies on T lymphocyte activation I. Requirements for the mitogen-dependent production of T cell growth factors | Q40725763 | ||
| The role of mitogenic lectins in T-cell triggering | Q41645123 | ||
| Long term culture of tumour-specific cytotoxic T cells | Q42799119 | ||
| Separation of Cells According to Surface Antigens by the Use of Antibody-Coated Columns. Fractionation of Cells Carrying Immunoglobulins and Blood Group Antigen | Q52258668 | ||
| Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines | Q67014094 | ||
| Isoelectric focusing in layers of granulated gels. I. Thin-layer isoelectric focusing of proteins | Q93736945 | ||
| P433 | issue | 5748 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 664-666 | |
| P577 | publication date | 1980-02-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Two distinct factors are required for induction of T-cell growth | |
| P478 | volume | 283 |
| Q40098841 | A Suggested Mechanism for T Lymphocyte Activation: Implications on the Acquisition of Functional Reactivities |
| Q59095644 | A differentiation factor required for the expression of cytotoxic T-cell function |
| Q41875135 | A monoclonal antibody inhibiting leucocyte adhesion blocks induction of IL-2 production but not IL-2 receptor expression |
| Q41136822 | A role for protein kinase C activity in interleukin-1 (IL-1) induction of IL-2 gene expression but not in IL-1 signal transduction |
| Q40118978 | Accessory Cells and T Cell Activation. The Relationship Between Two Components of Macrophage Accessory Cell Function: I-A and IL1 |
| Q68831040 | Accessory cell functions of dendritic cells and macrophages in the thymic T-cell response to Con A |
| Q68931614 | Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor |
| Q52270581 | Accessory function of human tumor cell lines. I. Production of interleukin 1 by the human histiocytic lymphoma cell line U-937. |
| Q34334781 | Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. |
| Q44323153 | Administration of interleukin-2 induces major histocompatibility complex class II expression on the biliary epithelial cells, possibly through endogenous interferon-gamma production |
| Q72711532 | Adriamycin-induced activation of NK activity may initially involve LAF production |
| Q70997153 | Analysis by limiting dilution of interleukin 2-producing T cells in murine ontogeny |
| Q35331741 | Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing |
| Q36319145 | Antigen-specific human T-cell hybridomas with helper activity |
| Q70275265 | Augmentation of NK cell activity by a circulating peptide isolated from the plasma of trauma patients |
| Q36324406 | B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor. |
| Q43706801 | BCG-induced suppressor T cells optimal conditions for in vitro induction and mode of action |
| Q41785350 | Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor |
| Q28573081 | Binding of interleukin 2 to gangliosides |
| Q36344249 | Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line |
| Q36314509 | Biochemical separation of a human B cell mitogenic factor |
| Q40135887 | Biological Properties of Interleukins |
| Q40109885 | Biological response modifiers and their promise in clinical medicine |
| Q72049283 | Cellular proliferation and cytokine responses to polymethylmethacrylate particles in patients with a cemented total joint arthroplasty |
| Q35614421 | Cloned T-cell proliferation and synthesis of specific proteins are inhibited by quinine |
| Q44623779 | Cloning of murine splenic T lymphocytes and natural killer (NK) cells on filter paper discs: detection of a novel NK/T phenotype |
| Q71689195 | Column separation of monocytes by adherence to gelatin beads |
| Q72107480 | Concanavalin A stimulation of mouse lymphocytes at low concentration. I. The effect of peritoneal exudate cells |
| Q42108238 | Concanavalin A-induced chemiluminescence in rat thymus lymphocytes. Its origin and role in mitogenesis |
| Q54533961 | Concanavalin A-induced resistance to Listeria monocytogenes and activation of macrophages: defect in mice treated with 89Sr. |
| Q36258532 | Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. |
| Q70227004 | Control of in Vitro Lymphocyte Proliferation by Copper, Magnesium and Zinc Deficiency |
| Q40131054 | Cyclosporin A - Usefulness, Risks and Mechanism of Action |
| Q70554049 | Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2 |
| Q38953841 | Cytokines and T-Cell Homeostasis in HIV Infection. |
| Q69614820 | Decreased immunogenicity of fetal kidneys: the role of passenger leukocytes |
| Q34379078 | Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients |
| Q36347685 | Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation |
| Q72117331 | Development and continuous growth in culture of interleukin 2-producer lymphocytes from athymic nu/nu mice |
| Q63245005 | Die Rolle von Interleukin-2 bei der Aktivierung von zytotoxischen T-Lymphozyten |
| Q72794789 | Differential requirements for activation and growth of unprimed cytotoxic and helper T lymphocytes |
| Q36348189 | Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markers |
| Q71824749 | Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration |
| Q36346534 | Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses |
| Q42114562 | Duration of the calcium signal in the mitogenic stimulation of thymocytes |
| Q68812326 | Effects of a human urinary mitogen on subpopulations of peripheral blood mononuclear leukocytes |
| Q52219135 | Effects of anti-Ig reagents on T cell functions I. Activation of rabbit T cells by anti-allotype antibodies |
| Q35109791 | Effects of recombinant human interleukin-1 beta on accumulation of inflammatory peritoneal macrophages in mice treated with pertussis toxin. |
| Q68314106 | Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells |
| Q36351065 | Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction |
| Q36996934 | Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation |
| Q45828113 | Enhancement of encephalomyeloradiculitis in mice sensitized with spinal cord tissue and infected with lactate dehydrogenase-elevating virus |
| Q36384274 | Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules |
| Q39479879 | Experimental strategies for the study of cellular immunity in renal disease |
| Q36302601 | Expression of Thy-1 antigen is not limited to T cells in cultures of mouse hemopoietic cells |
| Q37000483 | Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation |
| Q34632037 | Functional characterization of an antigen involved in an early step of T-cell activation |
| Q70475350 | Gamma-interferon induction in human lymphoblasts compared with fresh mononuclear leucocytes: earlier synthesis, rapid shut-off and enhancement of yields by metabolic inhibitors |
| Q70224913 | Heterogeneity in the response of T cells to antigens presented by B lymphoma cells |
| Q40265023 | Heterogeneity of cells and factors participating in the concanavalin A-dependent activation of T lymphocytes with cytotoxic potential. |
| Q70565830 | Heterogeneity of stimulator cells in the murine mixed leukocyte response |
| Q40334238 | Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor |
| Q72120045 | Human lymphocyte proliferation. II. Formation of activated (G1) cells |
| Q37562231 | Immunodeficiency with defective T-cell response to interleukin 1. |
| Q72785093 | Immunoregulation of the mixed lymphocyte reaction by macrophage-derived factors: functional and biochemical separation of enhancing and inhibitory factors |
| Q70985261 | Impaired production of interleukins in patients with cell-mediated immunodeficiencies |
| Q36344339 | In vitro analysis of allogeneic lymphocyte interaction. V. Identification and characterization of two components of allogeneic effect factor, one of which displays H-2-restricted helper activity and the other, T cell-growth factor activity |
| Q70990339 | In vitro correction of the interleukin 2 defect of autoimmune mice |
| Q37526076 | In vivo separation of two classes of T cells as determined by negative selection after the injection of UV-treated allogeneic lymphoid cells |
| Q70746590 | Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis |
| Q67921542 | Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis |
| Q70200979 | Induction and amplification of T-lymphocyte proliferative responses to periodate and soybean aggtutinin by human adult vascular endothelial cells |
| Q69867196 | Induction of proliferative and cytotoxic responses in resting Lyt-2+ T cells with lectin and recombinant interleukin 2 |
| Q69870955 | Influence of age on the production and regulation of interleukin-1 in mice |
| Q37052811 | Influence of estrogen on host resistance: increased susceptibility of mice to Listeria monocytogenes correlates with depressed production of interleukin 2. |
| Q64970650 | Inhibition of in vitro immunosuppressive effects of glucocorticosteroids by a competitive antagonist RU-486 |
| Q37542762 | Inhibition of soluble immune response suppressor activity by growth factors |
| Q57340004 | Intercellular communication and cell cooperation in growth control of T-lymphocytes |
| Q54799200 | Interferon gamma produced by mitogen-activated T lymphocytes does not directly mediate lymphoproliferation. |
| Q40264389 | Interleukin 1 and T cell activation |
| Q37557411 | Interleukin 1 can act as a B-cell growth and differentiation factor |
| Q36306868 | Interleukin 1 can replace the requirement for I-A-positive cells in the proliferation of antigen-primed T cells |
| Q36353332 | Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells |
| Q36355227 | Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors |
| Q53553480 | Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2 |
| Q72635049 | Interleukin 2 Production by Both Ly2+ and Ly2- T-Cell Subsets |
| Q70289413 | Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells |
| Q72812061 | Interleukin 2 induction of antigen-nonspecific suppressor cells |
| Q70305531 | Interleukin 2 is a proliferative signal for B cells from autoimmune mice |
| Q40145076 | Interleukin 2: Biology and biochemistry |
| Q70055693 | Interleukin 4 (BSF-1) induces growth in resting murine CD8 T cells triggered via cross-linking of T3 cell surface structures |
| Q72813177 | Interleukin-1 synthesis and activity in aged mice |
| Q71010455 | Interleukin-1-like activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte co-stimulator assay |
| Q39592975 | Interleukin-2 (IL-2) and its receptor. |
| Q72931066 | Intracellular p H of Mitogen-Stimulated Lymphocytes |
| Q70383856 | Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes |
| Q57200964 | Involvement of the CD4 molecule in a post-activation event on T cell proliferation |
| Q36363870 | Ligand-induced desensitization of interleukin 1 receptor-initiated intracellular signaling events in T helper lymphocytes |
| Q53568762 | Long-term growth and cloning of non-transformed lymphocytes. |
| Q55062774 | Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. |
| Q42935877 | Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo |
| Q40168178 | MHC-Restricted T Cell Activation: Analysis with T Cell Hybridomas |
| Q36273673 | Macrophage-derived growth factor for osteoblast-like cells and chondrocytes |
| Q39592983 | Malignant B-cells have receptors for and respond to interleukin-2. |
| Q40264396 | Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins |
| Q40105409 | Mediators of cellular immune reactions |
| Q67518401 | Minimal growth requirements of mature T lymphocytes: interleukin (IL)-1 and IL-6 increase growth rate but not plating efficiency of CD4 cells stimulated with anti-CD3 and IL-2 |
| Q36344206 | Mitogen-initiated synthesis and secretion of T cell growth factor(s) by a T-lymphoma cell line |
| Q69924605 | Mitogenic effects of phorbol myristate acetate (PMA) on amphibian cells |
| Q73292771 | Modulation of specific active immunization against murine melanoma using recombinant cytokines |
| Q70264117 | Modulatory effect of bucillamine (SA96) on interleukin-1-and/or -2-induced proliferation of T lymphocytes |
| Q40330090 | Molecular characterization of interleukin 2. |
| Q59662174 | Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function |
| Q69041463 | Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro |
| Q85702141 | Naming lymphocytespecific growth and differentiation factors |
| Q72815106 | On the role of I-A antigens in lectin- and antigen-induced interleukin 2 production |
| Q46511659 | Partial Characterization of Thymocyte-Activating Factor Derived from MDP-Stimulated Guinea Pig Fibroblasts |
| Q55245506 | Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2 — I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture |
| Q71012326 | Production and characterization of bovine interleukin-2 |
| Q43981598 | Production of interleukin-1 beta by periodic acid-oxidized human peripheral blood mononuclear cells |
| Q67765346 | Production of interleukin-1β and tumour necrosis factor-α in patients with benign or malignant ovarian tumours |
| Q36317057 | Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor |
| Q38307815 | Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes |
| Q36346251 | Prostaglandin E inhibits the production of human interleukin 2 |
| Q70234881 | Purification to Homogeneity of Biologically Active Human Interleukin 1 |
| Q44754731 | Pyrimidinone (bropirimine) mediated alteration of T lymphocyte subsets during murine cytomegalovirus infection |
| Q36406738 | Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes |
| Q72766880 | Rat lymphocyte subsets: Cellular requirements for the generation of T-cell growth factor |
| Q67294764 | Receptors for immunoglobulin isotypes (FcR) on murine T cells. II. Multiple FcR induction on hybridoma T cell clones |
| Q40110807 | Recognition of Self and Regulation of Specificity at the Level of Cell Populations |
| Q53573941 | Regulation of Human T-Cell Proliferation: T-Cell Growth Factor and Isolation of a New Class of Type-C Retroviruses from Human T-Cells |
| Q40105251 | Requirement for the Involvement of Clonally Distributed Receptors in the Activation of Cytotoxic T Lymphocytes |
| Q36346735 | Requirement for three signals in B cell responses. II. Analysis of antigen- and Ia-restricted T helper cell-B cell interaction |
| Q70565957 | Role of individual chains of HLA-DR antigens in activation of T cells induced by alloantigens |
| Q36347822 | Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation |
| Q68828813 | Role of interleukin-1 in B-cell activation |
| Q68130317 | Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation |
| Q72774000 | Selective protection of murine thymic helper T cells from glucocorticosteroid inhibition by macrophage-derived mediators |
| Q41627670 | Signal transduction by interleukin 2 in human T cells: Activation of tyrosine and ribosomal S6 kinases and cell‐cycle regulatory genes |
| Q71575620 | Soluble factor activation of human B lymphocytes |
| Q41435191 | Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects |
| Q70425197 | Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities |
| Q40300528 | Strategies for the analysis of accessory-cell function: the in vitro cloning and characterization of the P cell |
| Q67930623 | Stressor-induced changes in mitogenic activity are not associated with decreased interleukin 2 production or changes in lymphocyte subsets |
| Q70320553 | Studies on the accessory requirement for T lymphocyte activation by concanavalin A |
| Q41510576 | Studies on the in vivo production of a lymphokine activity, interleukin 3 (IL-3) elaborated by lymphocytes and a myeloid leukaemic line in vitro and the fate of IL-3 dependent cell lines |
| Q68100013 | Studies on the release of cell-associated interleukin 1 by paraformaldehyde-treated murine macrophages |
| Q55265276 | Suppressive Activity of Interleukin 4 on the Induction of Antigen-specific Cytotoxic T Cells in Humans |
| Q44601327 | Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice |
| Q54357179 | Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors. |
| Q40101287 | T cell clones: Their use for the study of specificity, induction, and effector-function of T cells |
| Q68801690 | T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2 |
| Q36345824 | T cell growth factor receptors. Quantitation, specificity, and biological relevance |
| Q69869597 | T cell triggering by lectins. I. Requirements for interleukin 2 production; lectin concentration determines the accessory cell dependency |
| Q40102015 | T-Cell Growth Factor and the Culture of Cloned Functional T Cells |
| Q35425292 | T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation |
| Q72807441 | T-T cell interactions during in vitro cytotoxic T cell responses. VI. The role of T cell-derived colony-stimulating factor in helper T cell activation |
| Q42165281 | T-T cell interactions during in vitro cytotoxic T lymphocyte responses. V. Precursor frequencies and specificity of alloreactive helper T cells |
| Q40293133 | T-cell growth factor |
| Q40218602 | T-lymphocyte colony growth in vitro: factors modulating clonal expansion |
| Q40104730 | The Biology of Monoclonal Lymphokines Secreted by T Cell Lines and Hybridomas |
| Q40115119 | The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy |
| Q72684123 | The Regulation of T Cell Growth: Requirements for the Activation and Replication of Antigen-Specific Interleukin 2 Producing T Cells |
| Q58620215 | The Replacement of Monocytes and Interleukin-1 by Phorbol Ester in Lectin-Induced Proliferation of Human Thymocytes and T Cells |
| Q36617483 | The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients |
| Q40330084 | The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses |
| Q70230144 | The differential effects of hydrocortisone on activation and tolerance induction in human T lymphocyte clones |
| Q70152854 | The effect of hydrocortisone (HC) on sodium periodate and phytohemagglutinin-induced [3H]thymidine incorporation and lymphokine production by human lymphocytes |
| Q40834262 | The pyrogenic and mitogenic actions of interleukin-1 are related |
| Q43651719 | The relationship between epithelial Ia expression and the inflammatory cell infiltrate during experimental oral carcinogenesis |
| Q38247896 | The role of interleukin-1 in the immunological response |
| Q39572319 | The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response |
| Q70482493 | Theory and practice of immunoregulation by tissue treatment prior to transplantation |
| Q41587468 | Total joint arthroplasty and the immune response |
| Q42936742 | Transient expression of interleukin 2 receptors. Consequences for T cell growth |
| Q41667500 | Tumor necrosis factor-α, interleukin 1, and phorbol myristate acetate are independent activators of NF-κB which differentially activate T cells |
| Q72785449 | Ultraviolet Radiation Inhibits Alloantigen Presentation by Epidermal Cells: Partial Reversal by the Soluble Epidermal Cell Product, Epidermal Cell-Derived Thymocyte-Activating Factor (ETAF) |
| Q37679686 | Xenogeneic antiserum to soluble products from activated lymphoid cells inhibits interleukin 1-mediated functions in the helper pathway of cytolytic-effector-cell differentiation |
| Q71559054 | [T-lymphocyte activation. Studies on the function of mediator proteins (author's transl)] |
Search more.